Abstract
The small GTPase Rho is important for cell cycle progression and Ras transformation in fibroblasts. However, it is unclear whether Rho is needed for proliferation in other cell types, and its targets in promoting normal cell cycle progression are unknown. Here, we demonstrate that Rho is required for G1 to S progression in MCF10A mammary epithelial cells, both in response to EGF and in response to oncogenic Ras. We describe two effects of Rho, the repression of p21CIP1 and the induction of cyclin D1, that may underlie its role in promoting S phase entry. The Rho inhibitor, C3 exotransferase, induced p21CIP1 both in EGF-stimulated and V12Ras-expressing cells. In addition, C3 blocked EGF-stimulated cyclin D1 promoter activity whereas V14RhoA induced the cyclin D1 promoter and cooperated with V12Ras in cyclin D1 induction. Finally, a high proportion of cells co-expressing V14RhoA and V12Ras displayed lobulated, polyploid nuclei that were actively synthesizing DNA. Our results demonstrate that Rho plays a fundamental role in promoting Ras-dependent S phase entry in mammary epithelial cells, whether in response to normal or oncogenic signaling, and indicate that in cells expressing oncogenic Ras, the activation of Rho diminishes p21CIP1 expression, increases cyclin D1 promoter activity, and uncouples DNA synthesis from mitosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aktories K, Just I . 1995 Methods Enzymol. 256: 184–195
Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG . 1995 J. Biol. Chem. 270: 23589–23597
Barbacid M . 1987 Annu. Rev. Biochem. 56: 779–827
Bartkova J, Lukas J, Muller H, Lutzhoft D, Strauss M, Bartek J . 1994 Int. J. Cancer 57: 353–361
Cerione RA, Zheng Y . 1996 Curr. Opin. Cell. Biol. 8: 216–222
Dulic V, Stein GH, Far DF, Reed SI . 1998 Mol. Cell. Biol. 18: 546–557
Eva A, Aaronson SA . 1985 Nature 316: 273–275
Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G . 1994 Cancer Res. 54: 1812–1817
Gudas Nguyen H, Li T, Hill D, Cowan KH . 1995 Oncogene 11: 253–261
Joyce D, Bouzahzah B, Fu M, Albanese C, D'Amico M, Steer J, Klein JU, Lee RJ, Segall JE, Westwick JK, Der CJ, Pestell RG . 1999 J. Biol. Chem. 274: 25245–25249
Kerkhoff E, Rapp UR . 1998a Oncogene 17: 1457–1462
Kerkhoff E, Rapp UR . 1998b Cancer Res. 58: 1636–1640
Khosravi-Far R, Campbell S, Rossman KL, Der CJ . 1997 Advances Cancer Res. 72: 72–107
Kortenjann M, Thomae O, Shaw PE . 1994 Mol. Cell. Biol. 14: 4815–4824
Lee RJ, Albanese C, Fu M, D'Amico M, Lin B, Watanabe G, Haines III GK, Siegel PM, Hung MC, Yarden Y, Horowitz JM, Muller WJ, Pestell RG . 2000 Mol. Cell. Biol. 20: 672–683
Li Y, Jenkins CW, Nichols MA, Xiong Y . 1994 Oncogene 9: 2261–2268
Liberto M, Cobrinik D . 2000 Cancer Lett. 154: 151–161
Lin R, Cerione RA, Manor D . 1999 J. Biol. Chem. 274: 23633–23641
Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T . 1995 Genes Dev. 9: 935–944
Mantel C, Braun SE, Reid S, Henegariu O, Liu L, Hangoc G, Broxmeyer HE . 1999 Blood 93: 1390–1398
Marshall C . 1995 Cell 80: 179–185
Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D . 1994 Cancer Res. 54: 3391–3395
Minden A, Lin A, Claret FX, Abo A, Karin M . 1995 Cell 81: 1147–1157
Niculescu III AB, Chen X, Smeets M, Hengst L, Prives C, Reed SI . 1998 Mol. Cell. Biol. 18: 629–643
Nobes CD, Hall A . 1995 Cell 81: 53–62
Olson MF, Ashworth A, Hall A . 1995 Science 269: 1270–1272
Olson MF, Paterson HF, Marshall CJ . 1998 Nature 394: 295–299
Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR Draetta GF, Rolfe M . 1995 Science 269: 682–685
Page K, Li J, Hodge JA, Liu PT, Vanden Hoek TL, Becker LB, Pestell RG, Rosner MR, Hershenson MB . 1999 J. Biol. Chem. 274: 22065–22071
Prendergast GC, Khosravi-Far R, Solski PA, Kurzawa H, Lebowitz P, Der CJ . 1995 Oncogene 10: 2289–2296
Qiu RG, Abo A, McCormick F, Symons M . 1997 Mol. Cell. Biol. 17: 3449–3458
Qiu RG, Chen J, Kirn D, McCormick F, Symons M . 1995a Nature 374: 457–459
Qiu RG, Chen J, McCormick F, Symons M . 1995b Proc. Natl. Acad. Sci. USA 92: 11781–11785
Ron D, Tronick SR, Aaronson SA, Eva A . 1988 EMBO J. 7: 2465–2473
Sahai E, Ishizaki T, Narumiya S, Treisman R . 1999 Curr. Biol. 9: 136–145
Sicinski P, Weinberg RA . 1997 J. Mammary Gland Biol. Neoplasia. 2: 335–342
Soule HD, Maloney TM, Wolman SR, Peterson Jr WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC . 1990 Cancer Res. 50: 6075–6086
Stewart ZA, Leach SD, Pietenpol JA . 1999 Mol. Cell. Biol. 19: 205–215
Tombes RM, Auer KL, Mikkelsen R, Valerie K, Wymann MP, Marshall CJ, McMahon M, Dent P . 1998 Biochem. J. 330: 1451–1460
Troppmair J, Bruder JT, Munoz H, Lloyd PA, Kyriakis J, Banerjee P, Avruch J, Rapp UR . 1994 J. Biol. Chem. 269: 7030–7035
Van Aelst L, D'Souza-Schorey C . 1997 Genes Dev. 11: 2295–2322
Waldman T, Lengauer C, Kinzler KW, Vogelstein B . 1996 Nature 381: 713–716
Westwick JK, Lambert GT, Clark GJ, Symons M, Van Aelst L, Pestell RG, Der CJ . 1997 Mol. Cell. Biol. 17: 1324–1335
Westwick JK, Lee RJ, Lambert QT, Symons M, Pestell RG, Der CJ, Whitehead IP . 1998 J. Biol. Chem. 273: 16739–16747
Woods D, Parry D, Cherwinski H, Boxch E, Lees E, McMahon M . 1997 Mol. Cell. Biol. 17
Yamamoto M, Marui N, Sakai T, Morii N, Kozaki S, Ikai K, Imamura S, Narumiya S . 1993 Oncogene 8: 1449–1455
Yu Q, Geng Y, Sicinski P . 2001 Nature 411: 1017–1021
Zhou P, Jiang W, Weghorst CM, Weinstein IB . 1996 Cancer Res. 56: 36–39
Acknowledgements
We thank Richard Pestell for the Cyclin D1 promoter construct. This work was supported by R01 CA76342 and an American Scientist Development Grant Award from the American Heart Association to A Minden and DAMD17-98-1-8051 from the United States Army Breast Cancer Research Program to D Cobrinik
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Liberto, M., Cobrinik, D. & Minden, A. Rho regulates p21CIP1, cyclin D1, and checkpoint control in mammary epithelial cells. Oncogene 21, 1590–1599 (2002). https://doi.org/10.1038/sj.onc.1205242
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205242
Keywords
This article is cited by
-
Adenovirus-mediated RhoA shRNA suppresses growth of esophageal squamous cell carcinoma cells in vitro and in vivo
Medical Oncology (2012)
-
GTPase regulator associated with the focal adhesion kinase (GRAF) transcript was down-regulated in patients with myeloid malignancies
Journal of Experimental & Clinical Cancer Research (2010)
-
Stability of p21Waf1/Cip1 CDK inhibitor protein is responsive to RhoA-mediated regulation of the actin cytoskeleton
Oncogene (2006)
-
Multifaceted Role of Rho Proteins in Angiogenesis
Journal of Mammary Gland Biology and Neoplasia (2005)
-
Integrin-dependent signal transduction regulating cyclin D1 expression and G1 phase cell cycle progression
Cancer and Metastasis Reviews (2005)